Zhejiang Chengyi Pharmaceutical Co. Ltd.SSE: 603811

Report for Q3 2024

Oct 29, 2024 · Issued by Zhejiang Chengyi Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Oct 29, 2024

On 6ix: 6ix.com/news/report-for-q3-2024-239

Report for Q3 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Zhejiang Chengyi Pharmaceutical Co. Ltd. on 6ix

Later from Zhejiang Chengyi Pharmaceutical

Announcement on Obtaining Share Repurchase Loans from Financial InstitutionsNov 8, 2024
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024Nov 14, 2024
Announcement on Outline of the Q3 2024 Performance BriefingNov 19, 2024
Announcement on Progress in Repurchasing 2% of Shares through Call AuctionDec 24, 2024
Announcement on the Acquisition of Drug Registration Certificate for Calcitriol Soft CapsulesJan 3, 2025

All Zhejiang Chengyi Pharmaceutical news releases

Follow Zhejiang Chengyi Pharmaceutical into a list and get an email when it puts out news.

Follow Zhejiang Chengyi Pharmaceutical